Purchase Order 75N93023P01164

Award Date 8/30/23
Potential Completion Date 10/31/23
Potential Value $76K
Ultimate Awardee
Not listed
PSC Category
6810 - Chemicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46256, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $11,346 firm fixed price purchase order to Roche Diagnostics Corporation. The contract is for the delivery of Roche Diagnostics library preparation reagents to support research activities at the NIH campus in Gaithersburg, Maryland. The original solicitation sought brand name or equal reagents on a multiple delivery schedule to be provided under simplified...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $221,667.07 firm fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer, for COVID-19 research library preparation reagent kits. The order includes KAPA HyperExplore MAX 20Mb reagent kits and KAPA Universal Adapter products, to be delivered to the NIH Rocky Mountain Laboratories in Montana. The...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $150,000 firm fixed price purchase order to Roche Diagnostics Corporation. The contract is for the delivery of a COBAS 5800 SYSTEM to support research efforts at the NIH campus in Bethesda, Maryland. Roche will provide the analytical laboratory equipment in accordance with the brand name specifications outlined in the combined synopsis/solicitation. The...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Roche Diagnostics Corporation for $33,063.35. The contract is for reagents required for staining histological samples in flu research, with a completion date of September 26, 2024. The contract has no set-aside designation. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and...
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed price purchase order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for an annual maintenance agreement on three Roche Discovery Ultra laboratory instruments located in Hamilton, MT. The $43,196.25 contract provides technical support, preventive maintenance, and software updates for the equipment,...
This firm-fixed-price federal contract award to Roche Diagnostics Corporation, valued at $4,984.15, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) within the Department of Health and Human Services. The contract provides for the delivery of Roche Diagnostics kits and reagents to support NIAID's medical research and healthcare activities. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, laboratory instruments, and associated products...
Roche Diagnostics Corporation has been awarded a $13,557.70 firm fixed price purchase order contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide KAPA HYPEREXPLORE MAX and RNA HYPER KITS. The place of performance will be Roche's facility located in Castleton, Indiana. The contract period of performance spans from September 20, 2023 through January 31, 2024. No set aside designation or subcontractors were indicated. The National Institute...
This federal contract award, valued at $6,668.32, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The award is for the provision of discovery consumables and reagents, and does not have a set-aside designation. Roche Diagnostics has previously received...
The National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services, has awarded a sole-source 12-month maintenance agreement to Roche Diagnostics Corporation for two Roche "Discovery Ultra" instruments located in Hamilton, Montana. The contract, valued at $36,241.06, will provide comprehensive maintenance services including unlimited service visits, 24/7 customer support, and...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $22,902.60, was awarded to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for "DRUGS AND BIOLOGICALS" and has a...

The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $75,657.96 firm fixed price purchase order to Roche Diagnostics Corporation. The contract is for Roche Diagnostics Library Preparation Reagents to be delivered to the NIH Rocky Mountain Labs location in Hamilton, Montana. The solicitation requested brand name or equal reagents, as described in the attached bill of materials, to support the National Institute of Allergy and Infectious Diseases' research efforts. There was no set aside designation for this award. Performance is required between August 30, 2023 and October 31, 2023.

Generated 12/23/23, 6:23 AM